Kapur Anil
- SEC CIK
- 0001730703
No open-market purchases or sales filed in the past year.
Current role at each company
- VSTM Verastem, Inc.Directoras of May 26, 2026
- NRIX Nurix Therapeutics, Inc.Directoras of May 15, 2026
- GERN Geron CorpEVP, Corp Strategy & CCOas of Jun 12, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Kapur Anil as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
GERN Geron Corp
EVP, Corp Strategy & CCO1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 12, 2024 (view filing) | Jun 10 | 2 days | Kapur AnilEVP, Corp Strategy & CCO | SSale | −421.9K | $4.65 | −$1.96M | −100.0%0 after |